novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug Lilly, Novo MFN deals expected
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29

























